- Login
- Register & Subscribe
- Sprache: EN FR DE
Research & University News
Leukaemia patients remain in remission after gene transfer therapy
Monday 10 December 2012
Two out of the three patients with chronic lymphoid leukaemia (CLL) who were treated with a novel immunotherapy in 2010 remain healthy and in full remission more than two years after treatment, according to University of Pennsylvania researchers.
Location
United States
Roche to lead new IMI stem-cell project
Thursday 6 December 2012
The Roche Group is to coordinate a new project under the Innovative Medicines Initiative (IMI) under which 1,500 induced pluripotent stem (iPS) cell lines will be generated and characterised for use in the study of disease.
Location
Belgium
UK to create iPS cell repository
Friday 23 November 2012
Leading institutions in the UK, including the Wellcome Trust, have announced plans to create a repository of induced pluripotent stem cells (iPS) in order to study how genetic variation and defects impact cell behaviour and disease.
Location
United Kingdom
US, Chinese cancer researchers discuss collaboration
Friday 2 November 2012
A new effort to accelerate research into treatments for cancer is being made by researchers in the US and China who will meet in Beijing from 4 to 6 November to exchange information on modern molecular medicines as well as Chinese medicine.
Location
United States
Shire to study rare diseases with Italian charity
Wednesday 24 October 2012
In a move to strengthen its rare disease franchise, Shire Plc has entered into a research deal with Fondazione Telethon, an Italian biomedical charity, to investigate a number of lysosomal storage disorders and neurodegenerative diseases.
Location
Switzerland
Nobel Prize awarded to cell biology pioneers
Monday 8 October 2012
Two pioneers in cell biology, John Gurdon of the UK and Shinya Yamanaka of Japan, have been awarded the 2012 Nobel Prize in Physiology or Medicine for their work in showing that mature cells can be reprogrammed to become pluripotent.
Location
Sweden
MRC Technology reports on antibody project
Thursday 20 September 2012
A research project supported by MRC Technology of the UK and directed at new treatments for Alzheimer’s disease, has reached an important threshold with the humanisation of a next-generation antibody binding to amyloid beta.
Location
United Kingdom
Brain neurons and diet said to influence obesity
Tuesday 18 September 2012
New research published in the EMBO Journal suggests that a specific type of neuron in the brain can influence the way the body breaks down and stores nutrients, providing further insight into obesity and other metabolic diseases.
Location
Germany
MRC to open up its compound library to researchers
Monday 17 September 2012
Up to 9,000 small-molecule compounds with potential as future drugs are being made available free of charge to academic researchers around the world by MRC Technology, the technology transfer arm of the UK’s Medical Research Council.
Location
United Kingdom
AZ and Broad Institute to work on infection
Monday 10 September 2012
AstraZeneca Plc and the Broad Institute in Cambridge, Massachusetts, US have announced a collaboration to identify new chemical compounds targeting bacterial and viral infections. Financial details were not disclosed.
Location
United Kingdom
Select a News Category
Recent Appointments
Pascale Witz to head strategic development at Sanofi
Monday May 6 2013
Srinivas Akkaraju joins Sofinnova Ventures
Monday May 6 2013
Vicente Anido nominated to Nicox board
Monday May 6 2013
Jeremy Farrar named director of the Wellcome Trust
Monday May 6 2013
Harry Kirsch becomes CFO at Novartis
Monday May 6 2013